Ansell SM - Search Results

1

Genetic diversity of newly diagnosed follicular lymphoma.

Asmann YW, Maurer MJ, Wang C, Sarangi V, Ansell SM, Feldman AL, Nowakowski GS, Manske M, Price-Troska T, Yang ZZ, Slager SL, Habermann TM, Cerhan JR, Novak AJ. Asmann YW, et al. Among authors: ansell sm. Blood Cancer J. 2014 Oct 31;4(10):e256. doi: 10.1038/bcj.2014.80. Blood Cancer J. 2014. PMID: 25360902 Free PMC article. No abstract available.

2

Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.

Ansell SM, Habermann TM, Kurtin PJ, Witzig TE, Chen MG, Li CY, Inwards DJ, Colgan JP. Ansell SM, et al. J Clin Oncol. 1997 Jun;15(6):2296-301. doi: 10.1200/JCO.1997.15.6.2296. J Clin Oncol. 1997. PMID: 9196143

3

Primary laryngeal lymphoma.

Ansell SM, Habermann TM, Hoyer JD, Strickler JG, Chen MG, McDonald TJ. Ansell SM, et al. Laryngoscope. 1997 Nov;107(11 Pt 1):1502-6. doi: 10.1097/00005537-199711000-00014. Laryngoscope. 1997. PMID: 9369397

4

Primary thyroid lymphoma.

Ansell SM, Grant CS, Habermann TM. Ansell SM, et al. Semin Oncol. 1999 Jun;26(3):316-23. Semin Oncol. 1999. PMID: 10375088 Review.

5

Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.

Ansell SM, Kurtin PJ, Stenson M, Habermann TM, Greipp PR, Therneau TM, Witzig TE. Ansell SM, et al. Leuk Lymphoma. 1999 Aug;34(5-6):529-37. doi: 10.3109/10428199909058480. Leuk Lymphoma. 1999. PMID: 10492076

6

Cd4+ T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome.

Ansell SM, Stenson M, Habermann TM, Jelinek DF, Witzig TE. Ansell SM, et al. J Clin Oncol. 2001 Feb 1;19(3):720-6. doi: 10.1200/JCO.2001.19.3.720. J Clin Oncol. 2001. PMID: 11157023

7

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, Gastineau DA, Dispenzieri A, Ansell SM, Micallef IN, Geyer SM, Markovic SN. Porrata LF, et al. Among authors: ansell sm. Blood. 2001 Aug 1;98(3):579-85. doi: 10.1182/blood.v98.3.579. Blood. 2001. PMID: 11468153 Free article.

8

Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.

Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers TA, Folsom AR. Cerhan JR, et al. Among authors: ansell sm. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1466-71. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433728

9

Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.

Ansell SM, Arendt BK, Grote DM, Jelinek DF, Novak AJ, Wellik LE, Remstein ED, Bennett CF, Fielding A. Ansell SM, et al. Leukemia. 2004 Mar;18(3):616-23. doi: 10.1038/sj.leu.2403281. Leukemia. 2004. PMID: 14749704

10

Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.

Porrata LF, Ristow K, Witzig TE, Tuinistra N, Habermann TM, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Markovic SN. Porrata LF, et al. Among authors: ansell sm. Leukemia. 2007 Dec;21(12):2554-6. doi: 10.1038/sj.leu.2404819. Epub 2007 Jun 21. Leukemia. 2007. PMID: 17581607 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters